LONDON/NEW DELHI: The first set of results from early-stage clinical trials of the Oxford University Covid-19 vaccine candidate show the vaccine is safe and induces an immune reaction, according to results published in the Lancet, a medical journal, on Monday.
The results from Oxford were followed by Indian vaccine manufacturer Serum Institute announcing it would seek regulatory approvals for clinical trials in India and "soon start manufacturing the vaccine in large volumes". Serum Institute has a manufacturing arrangement with British pharma giant
AstraZenecato produce a billion doses if the Oxford University vaccine candidate was successful.
"The trials have shown promising results… We will be applying for the licensure trials to the Indian regulator in a week’s time," Serum Institute of India chief executive Adar Poonawalla said, adding that trials in would begin as soon as the approvals were in place.
Source : Times of india
1 Comments:
Hope, india may soon develop it. ✌️
Post a Comment